_id
690da929ccc777a4e85d082e
Ticker
ACON
Name
Aclarion Inc
Exchange
NASDAQ
Address
8181 Arista Place, Broomfield, CO, United States, 80021
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.aclarion.com
Description
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and data transfer products, including AMBRA Healthcare, an imaging data transfer platform and NOCIWEB, a custom developed web-interface. In addition, it offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Last Close
3.83
Volume
72360
Current Price
3.86
Change
0.01
Last Updated
2026-01-21T20:30:28.935Z
Image
data:image/webp;base64,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
Ipo Date
2022-04-22T00:00:00.000Z
Market Cap
3581581
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9963333333333333
Sentiment Sources
3
Rating
5
Target Price
22
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
18942
Cost Of Revenue
14556
Gross Profit
4386
Operating Expenses
1835350
Operating Income
-1830964
Interest Expense
0
Pretax Income
-1706294
Net Income
-1706294
Eps
-2.929908941207581
Dividends Per Share
5425
Shares Outstanding
582371
Income Tax Expense
-
EBITDA
-1647930
Operating Margin
-9666.15985640376
Total Other Income Expense Net
124670
Cash
11341336
Short Term Investments
-
Receivables
32018
Inventories
-
Total Current Assets
11904746
Property Plant Equipment
13164
Total Assets
13200298
Payables
274359
Short Term Debt
-
Long Term Debt
-
Total Liabilities
699747
Equity
12500551
Bs_currency_symbol
USD
Depreciation
58364
Change In Working Capital
470813
Cash From Operations
-1160372
Capital Expenditures
7318
Cash From Investing
-40151
Cash From Financing
-283798
Net Change In Cash
-1484321
Cf_currency_symbol
USD
PE
-
PB
0.17982823797127023
ROE
-13.649750319005937
ROA
-12.926177878711526
FCF
-1167690
Fcf Percent
-61.64554957237884
Piotroski FScore
0
Health Score
33
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
8
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
18942
Quarters > 0 > income Statement > cost Of Revenue
14556
Quarters > 0 > income Statement > gross Profit
4386
Quarters > 0 > income Statement > operating Expenses
1835350
Quarters > 0 > income Statement > operating Income
-1830964
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-1706294
Quarters > 0 > income Statement > net Income
-1706294
Quarters > 0 > income Statement > eps
-2.929908941207581
Quarters > 0 > income Statement > dividends Per Share
5425
Quarters > 0 > income Statement > shares Outstanding
582371
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1647930
Quarters > 0 > income Statement > operating Margin
-9666.15985640376
Quarters > 0 > income Statement > total Other Income Expense Net
124670
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
11341336
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
32018
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11904746
Quarters > 0 > balance Sheet > property Plant Equipment
13164
Quarters > 0 > balance Sheet > total Assets
13200298
Quarters > 0 > balance Sheet > payables
274359
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
699747
Quarters > 0 > balance Sheet > equity
12500551
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1706294
Quarters > 0 > cash Flow > depreciation
58364
Quarters > 0 > cash Flow > change In Working Capital
470813
Quarters > 0 > cash Flow > cash From Operations
-1160372
Quarters > 0 > cash Flow > capital Expenditures
7318
Quarters > 0 > cash Flow > cash From Investing
-40151
Quarters > 0 > cash Flow > cash From Financing
-283798
Quarters > 0 > cash Flow > net Change In Cash
-1484321
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-2.929908941207581
Quarters > 0 > ratios > PB
0.17982823797127023
Quarters > 0 > ratios > ROE
-13.649750319005937
Quarters > 0 > ratios > ROA
-12.926177878711526
Quarters > 0 > ratios > FCF
-1167690
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-61.64554957237884
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
19319
Quarters > 1 > income Statement > cost Of Revenue
14179
Quarters > 1 > income Statement > gross Profit
5140
Quarters > 1 > income Statement > operating Expenses
1741648
Quarters > 1 > income Statement > operating Income
-1736508
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-1600757
Quarters > 1 > income Statement > net Income
-1600757
Quarters > 1 > income Statement > eps
-2.748689409328418
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
582371
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1548195
Quarters > 1 > income Statement > operating Margin
-8988.601894507996
Quarters > 1 > income Statement > total Other Income Expense Net
135751
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
12825657
Quarters > 1 > balance Sheet > short Term Investments
39002
Quarters > 1 > balance Sheet > receivables
20920
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
13440755
Quarters > 1 > balance Sheet > property Plant Equipment
6461
Quarters > 1 > balance Sheet > total Assets
14754520
Quarters > 1 > balance Sheet > payables
281516
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
564422
Quarters > 1 > balance Sheet > equity
14190098
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1600757
Quarters > 1 > cash Flow > depreciation
52562
Quarters > 1 > cash Flow > change In Working Capital
-345732
Quarters > 1 > cash Flow > cash From Operations
-1865612
Quarters > 1 > cash Flow > capital Expenditures
478
Quarters > 1 > cash Flow > cash From Investing
-44002
Quarters > 1 > cash Flow > cash From Financing
-1
Quarters > 1 > cash Flow > net Change In Cash
-1909615
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-2.748689409328418
Quarters > 1 > ratios > PB
0.1584169510316278
Quarters > 1 > ratios > ROE
-11.280802993749585
Quarters > 1 > ratios > ROA
-10.849265174333018
Quarters > 1 > ratios > FCF
-1866090
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-96.5935089807961
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
18991
Quarters > 2 > income Statement > cost Of Revenue
23479
Quarters > 2 > income Statement > gross Profit
-4488
Quarters > 2 > income Statement > operating Expenses
1487437
Quarters > 2 > income Statement > operating Income
-1491925
Quarters > 2 > income Statement > interest Expense
271
Quarters > 2 > income Statement > pretax Income
-2037436
Quarters > 2 > income Statement > net Income
-2037436
Quarters > 2 > income Statement > eps
-9.287838589389422
Quarters > 2 > income Statement > dividends Per Share
5425
Quarters > 2 > income Statement > shares Outstanding
219366
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1982269
Quarters > 2 > income Statement > operating Margin
-7855.958085408878
Quarters > 2 > income Statement > total Other Income Expense Net
-545511
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
14750272
Quarters > 2 > balance Sheet > short Term Investments
39003
Quarters > 2 > balance Sheet > receivables
19172
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
15157353
Quarters > 2 > balance Sheet > property Plant Equipment
5093
Quarters > 2 > balance Sheet > total Assets
16479677
Quarters > 2 > balance Sheet > payables
516268
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
699032
Quarters > 2 > balance Sheet > equity
15780645
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2037436
Quarters > 2 > cash Flow > depreciation
55167
Quarters > 2 > cash Flow > change In Working Capital
-679048
Quarters > 2 > cash Flow > cash From Operations
-2510782
Quarters > 2 > cash Flow > capital Expenditures
78288
Quarters > 2 > cash Flow > cash From Investing
-78288
Quarters > 2 > cash Flow > cash From Financing
16885681
Quarters > 2 > cash Flow > net Change In Cash
14296611
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-9.287838589389422
Quarters > 2 > ratios > PB
0.05365767749036874
Quarters > 2 > ratios > ROE
-12.91098050808443
Quarters > 2 > ratios > ROA
-12.363324839437084
Quarters > 2 > ratios > FCF
-2589070
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-136.33142014638514
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
10232
Quarters > 3 > income Statement > cost Of Revenue
20556
Quarters > 3 > income Statement > gross Profit
-10324
Quarters > 3 > income Statement > operating Expenses
1816452
Quarters > 3 > income Statement > operating Income
-1806220
Quarters > 3 > income Statement > interest Expense
271
Quarters > 3 > income Statement > pretax Income
-1989572
Quarters > 3 > income Statement > net Income
-1989572
Quarters > 3 > income Statement > eps
-1453.3031409788166
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1369
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-17652.658326817826
Quarters > 3 > income Statement > total Other Income Expense Net
-183399
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
453661
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
18326
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
824279
Quarters > 3 > balance Sheet > property Plant Equipment
5499
Quarters > 3 > balance Sheet > total Assets
2123483
Quarters > 3 > balance Sheet > payables
525582
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1153426
Quarters > 3 > balance Sheet > equity
970057
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2049250
Quarters > 3 > cash Flow > depreciation
52245
Quarters > 3 > cash Flow > change In Working Capital
568009
Quarters > 3 > cash Flow > cash From Operations
-922861
Quarters > 3 > cash Flow > capital Expenditures
60717
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
125141
Quarters > 3 > cash Flow > net Change In Cash
-858436
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1453.3031409788166
Quarters > 3 > ratios > PB
0.005447453087808242
Quarters > 3 > ratios > ROE
-205.09846328617806
Quarters > 3 > ratios > ROA
-93.69380400031457
Quarters > 3 > ratios > FCF
-983578
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-96.1276387802971
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
45724
Annuals > 0 > income Statement > cost Of Revenue
129767
Annuals > 0 > income Statement > gross Profit
-84043
Annuals > 0 > income Statement > operating Expenses
5429003
Annuals > 0 > income Statement > operating Income
-5513049
Annuals > 0 > income Statement > interest Expense
535470
Annuals > 0 > income Statement > pretax Income
-6992927
Annuals > 0 > income Statement > net Income
-6992927
Annuals > 0 > income Statement > eps
-7416.875609859573
Annuals > 0 > income Statement > dividends Per Share
59675
Annuals > 0 > income Statement > shares Outstanding
942.84
Annuals > 0 > income Statement > income Tax Expense
1
Annuals > 0 > income Statement > EBITDA
-6264322
Annuals > 0 > income Statement > operating Margin
-12057.232525588313
Annuals > 0 > income Statement > total Other Income Expense Net
-1479881
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
453661
Annuals > 0 > balance Sheet > short Term Investments
39003
Annuals > 0 > balance Sheet > receivables
18326
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
824279
Annuals > 0 > balance Sheet > property Plant Equipment
5499
Annuals > 0 > balance Sheet > total Assets
2123483
Annuals > 0 > balance Sheet > payables
531603
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1153426
Annuals > 0 > balance Sheet > equity
970057
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-6992927
Annuals > 0 > cash Flow > depreciation
193138
Annuals > 0 > cash Flow > change In Working Capital
-564244
Annuals > 0 > cash Flow > cash From Operations
-5271609
Annuals > 0 > cash Flow > capital Expenditures
321937
Annuals > 0 > cash Flow > cash From Investing
-321937
Annuals > 0 > cash Flow > cash From Financing
5026138
Annuals > 0 > cash Flow > net Change In Cash
-567408
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-7416.875609859573
Annuals > 0 > ratios > PB
0.0037516995393054226
Annuals > 0 > ratios > ROE
-720.8779484092172
Annuals > 0 > ratios > ROA
-329.3140091067364
Annuals > 0 > ratios > FCF
-5593546
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-122.33282302510716
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
75404
Annuals > 1 > income Statement > cost Of Revenue
75728
Annuals > 1 > income Statement > gross Profit
-324
Annuals > 1 > income Statement > operating Expenses
4875657
Annuals > 1 > income Statement > operating Income
-4875981
Annuals > 1 > income Statement > interest Expense
608288
Annuals > 1 > income Statement > pretax Income
-4911374
Annuals > 1 > income Statement > net Income
-4911374
Annuals > 1 > income Statement > eps
-79781.90383365822
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
61.56
Annuals > 1 > income Statement > income Tax Expense
-1
Annuals > 1 > income Statement > EBITDA
-4140415
Annuals > 1 > income Statement > operating Margin
-6466.475253302213
Annuals > 1 > income Statement > total Other Income Expense Net
-35393
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1021069
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
13424
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
1289369
Annuals > 1 > balance Sheet > property Plant Equipment
1782
Annuals > 1 > balance Sheet > total Assets
2459774
Annuals > 1 > balance Sheet > payables
760535
Annuals > 1 > balance Sheet > short Term Debt
1125724
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3187769
Annuals > 1 > balance Sheet > equity
-727995
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4911374
Annuals > 1 > cash Flow > depreciation
162671
Annuals > 1 > cash Flow > change In Working Capital
622872
Annuals > 1 > cash Flow > cash From Operations
-3646947
Annuals > 1 > cash Flow > capital Expenditures
119522
Annuals > 1 > cash Flow > cash From Investing
-119522
Annuals > 1 > cash Flow > cash From Financing
3314732
Annuals > 1 > cash Flow > net Change In Cash
-451737
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-79781.90383365822
Annuals > 1 > ratios > PB
-0.0003264055384995776
Annuals > 1 > ratios > ROE
674.6439192576872
Annuals > 1 > ratios > ROA
-199.66769304822313
Annuals > 1 > ratios > FCF
-3766469
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-49.950519866320086
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
60444
Annuals > 2 > income Statement > cost Of Revenue
65298
Annuals > 2 > income Statement > gross Profit
-4854
Annuals > 2 > income Statement > operating Expenses
5556714
Annuals > 2 > income Statement > operating Income
-5561568
Annuals > 2 > income Statement > interest Expense
1507546
Annuals > 2 > income Statement > pretax Income
-7068593
Annuals > 2 > income Statement > net Income
-7068593
Annuals > 2 > income Statement > eps
-167541.9056648495
Annuals > 2 > income Statement > dividends Per Share
415523
Annuals > 2 > income Statement > shares Outstanding
42.19
Annuals > 2 > income Statement > income Tax Expense
1506226
Annuals > 2 > income Statement > EBITDA
-5417426
Annuals > 2 > income Statement > operating Margin
-9201.191185229303
Annuals > 2 > income Statement > total Other Income Expense Net
-1507025
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1472806
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
18653
Annuals > 2 > balance Sheet > inventories
301331
Annuals > 2 > balance Sheet > total Current Assets
1701076
Annuals > 2 > balance Sheet > property Plant Equipment
3346
Annuals > 2 > balance Sheet > total Assets
2914629
Annuals > 2 > balance Sheet > payables
457558
Annuals > 2 > balance Sheet > short Term Debt
4644
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
688671
Annuals > 2 > balance Sheet > equity
2225958
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-7605542
Annuals > 2 > cash Flow > depreciation
193621
Annuals > 2 > cash Flow > change In Working Capital
805300
Annuals > 2 > cash Flow > cash From Operations
-5314171
Annuals > 2 > cash Flow > capital Expenditures
208870
Annuals > 2 > cash Flow > cash From Investing
-207870
Annuals > 2 > cash Flow > cash From Financing
6552318
Annuals > 2 > cash Flow > net Change In Cash
1030276
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-167541.9056648495
Annuals > 2 > ratios > PB
0.00007316103897737512
Annuals > 2 > ratios > ROE
-317.55284690906115
Annuals > 2 > ratios > ROA
-242.52119223407163
Annuals > 2 > ratios > FCF
-5523041
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-91.37451194494078
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
60292
Annuals > 3 > income Statement > cost Of Revenue
69175
Annuals > 3 > income Statement > gross Profit
-8883
Annuals > 3 > income Statement > operating Expenses
2944155
Annuals > 3 > income Statement > operating Income
-2953038
Annuals > 3 > income Statement > interest Expense
476479
Annuals > 3 > income Statement > pretax Income
-4950290
Annuals > 3 > income Statement > net Income
-4950290
Annuals > 3 > income Statement > eps
-99764.0064490125
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
49.62
Annuals > 3 > income Statement > income Tax Expense
-1415695
Annuals > 3 > income Statement > EBITDA
-4287423
Annuals > 3 > income Statement > operating Margin
-4897.893584555165
Annuals > 3 > income Statement > total Other Income Expense Net
-1997252
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
432530
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
6280
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
732204
Annuals > 3 > balance Sheet > property Plant Equipment
12636
Annuals > 3 > balance Sheet > total Assets
1889465
Annuals > 3 > balance Sheet > payables
1059546
Annuals > 3 > balance Sheet > short Term Debt
2000000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
7618784
Annuals > 3 > balance Sheet > equity
-5729319
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4950290
Annuals > 3 > cash Flow > depreciation
189373
Annuals > 3 > cash Flow > change In Working Capital
676287
Annuals > 3 > cash Flow > cash From Operations
-2349949
Annuals > 3 > cash Flow > capital Expenditures
1
Annuals > 3 > cash Flow > cash From Investing
-152005
Annuals > 3 > cash Flow > cash From Financing
2939500
Annuals > 3 > cash Flow > net Change In Cash
437546
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-99764.0064490125
Annuals > 3 > ratios > PB
-0.00003343036057164909
Annuals > 3 > ratios > ROE
86.40276444722313
Annuals > 3 > ratios > ROA
-261.9942682187815
Annuals > 3 > ratios > FCF
-2349950
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-38.97614940622305
Annuals > 3 > health Score
30
Valuation > metrics > PE
-2.929908941207581
Valuation > metrics > PB
0.17982823797127023
Valuation > final Score
70
Valuation > verdict
82.0% Undervalued
Profitability > metrics > ROE
-13.649750319005937
Profitability > metrics > ROA
-14.33288874873937
Profitability > metrics > Net Margin
-90.07992820187943
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.05597729252094567
Risk > metrics > Interest Coverage
-
Risk > final Score
-
Risk > verdict
High
Liquidity > metrics > Current Ratio
43.39112622512839
Liquidity > metrics > Quick Ratio
43.39112622512839
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-
Prev Risks > 1
-21961
Prev Risks > 2
-26630
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
89
Updated At
2026-01-21T20:30:29.675Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.93
Earnings History > 0 > eps Estimate
-0.17
Earnings History > 0 > eps Difference
-2.76
Earnings History > 0 > surprise Percent
-1623.5294
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-2.75
Earnings History > 1 > eps Estimate
-2.26
Earnings History > 1 > eps Difference
-0.49
Earnings History > 1 > surprise Percent
-21.6814
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-09
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1628.09
Earnings History > 2 > eps Estimate
-1356.74
Earnings History > 2 > eps Difference
-271.35
Earnings History > 2 > surprise Percent
-20.0001
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1628.0878
Earnings History > 3 > eps Estimate
-1356.7399
Earnings History > 3 > eps Difference
-271.3479
Earnings History > 3 > surprise Percent
-20
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1356.74
Earnings History > 4 > eps Estimate
-1628.09
Earnings History > 4 > eps Difference
271.35
Earnings History > 4 > surprise Percent
16.6668
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-23
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1356.7399
Earnings History > 5 > eps Estimate
-2080.3345
Earnings History > 5 > eps Difference
723.5946
Earnings History > 5 > surprise Percent
34.7826
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.44
Earnings History > 6 > eps Estimate
-0.57
Earnings History > 6 > eps Difference
0.13
Earnings History > 6 > surprise Percent
22.807
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-20
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.5329
Earnings History > 7 > eps Estimate
-1.6
Earnings History > 7 > eps Difference
0.0671
Earnings History > 7 > surprise Percent
4.1938
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.117
Earnings History > 8 > eps Estimate
-0.09
Earnings History > 8 > eps Difference
-0.027
Earnings History > 8 > surprise Percent
-30
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-07-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.15
Earnings History > 9 > eps Estimate
-0.1
Earnings History > 9 > eps Difference
-0.05
Earnings History > 9 > surprise Percent
-50
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.1
Earnings History > 10 > eps Estimate
-0.1
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-01
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.17
Earnings History > 11 > eps Estimate
-0.17
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.21
Earnings History > 12 > eps Estimate
-0.12
Earnings History > 12 > eps Difference
-0.09
Earnings History > 12 > surprise Percent
-75
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.49
Earnings History > 13 > eps Estimate
-0.11
Earnings History > 13 > eps Difference
-0.38
Earnings History > 13 > surprise Percent
-345.4545
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-06-06
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.35
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and data transfer products, including AMBRA Healthcare, an imaging data transfer platform and NOCIWEB, a custom developed web-interface. In addition, it offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$22
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.82% of the total shares of Aclarion Inc
1.
UBS Group AG(0.2969%)
since
2025/06/30
2.
Vanguard Institutional Extnd Mkt Idx Tr(0.2935%)
since
2025/07/31
3.
Fidelity Extended Market Index(0.1679%)
since
2025/07/31
4.
Spartan Total Market Index Pool G(0.0489%)
since
2025/07/31
5.
Tower Research Capital LLC(0.0129%)
since
2025/06/30
6.
Bank of America Corp(0.0014%)
since
2025/06/30
7.
CLEAR STREET LLC.(0.0005%)
since
2025/06/30
8.
State St US Extended Mkt Indx NL Cl C(0.0002%)
since
2025/08/31
9.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.93
EPS Estimate
-0.17
EPS Difference
-2.76
Surprise Percent
-1623.5294%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.